ModerateCaution
Magnesium may affect lithium excretion and distribution, as both are divalent cations handled by similar renal transport mechanisms. Changes in magnesium status can alter lithium levels. Additionally, lithium can itself cause magnesium wasting.
Recommendation: Monitor lithium levels when starting or stopping magnesium supplements. If magnesium supplementation is needed (which it may be, as lithium can deplete magnesium), start at a low dose and have lithium levels checked within 1-2 weeks.
InfoCaution
Zinc and lithium have minor interactions related to shared transport mechanisms and effects on thyroid function. While the interaction is not well-characterized, both affect thyroid hormone metabolism and monitoring is prudent.
Recommendation: The interaction is minor, but inform your prescriber if supplementing with zinc while on lithium. Continue routine lithium and thyroid monitoring as prescribed.
InfoSynergy
Fish oil (EPA/DHA) may have additive mood-stabilizing benefits when combined with lithium. Omega-3 fatty acids have demonstrated modest efficacy in bipolar disorder, and the combination may enhance therapeutic outcomes without significant adverse interaction risk.
Recommendation: Fish oil supplementation (1-2g EPA+DHA/day) may be a beneficial adjunct to lithium therapy for mood stabilization. No specific timing separation is needed. Discuss with your prescriber.
ModerateCaution
Both lithium and potassium are affected by renal excretion mechanisms, and changes in potassium balance can influence lithium handling. Potassium-sparing or potassium-wasting conditions can alter lithium levels, and the narrow therapeutic index of lithium makes even modest changes clinically relevant.
Recommendation: Maintain consistent potassium intake while on lithium. Avoid large, sudden changes in potassium supplementation. Monitor lithium levels and electrolytes regularly as prescribed.
SeriousCaution
ACE inhibitors reduce renal lithium clearance, potentially increasing lithium levels by 25-40% and causing lithium toxicity. Symptoms include tremor, nausea, confusion, and potentially seizures.
Recommendation: Monitor lithium levels closely when starting, stopping, or adjusting ACE inhibitor dose. Reduce lithium dose as needed. Watch for toxicity symptoms.
SeriousCaution
Thiazide diuretics reduce lithium clearance by 25-40%, significantly increasing the risk of lithium toxicity. This is one of the most well-documented drug-drug interactions involving lithium.
Recommendation: If combination is necessary, reduce lithium dose by 25-50% and monitor lithium levels frequently (weekly initially). Use lowest effective diuretic dose.
SeriousCaution
Loop diuretics can increase lithium levels through volume depletion, though the effect is generally less predictable than with thiazide diuretics. Dehydration from aggressive diuresis is particularly dangerous.
Recommendation: Monitor lithium levels closely. Ensure adequate hydration. Check lithium levels within 5-7 days of diuretic initiation or dose change.
ModerateCaution
While SSRIs and lithium are commonly used together in treatment-resistant depression and bipolar disorder, the combination carries a modest risk of serotonin syndrome and lithium augments serotonergic neurotransmission.
Recommendation: This combination is often used intentionally under psychiatric supervision. Monitor for serotonin syndrome symptoms, especially when initiating or increasing SSRI dose. Therapeutic lithium level monitoring remains essential.
ModerateCaution
Lithium concentrates in the thyroid and inhibits thyroid hormone synthesis. Iodine supplementation in lithium-treated patients can worsen lithium-induced hypothyroidism or paradoxically trigger thyrotoxicosis (Jod-Basedow effect).
Recommendation: Avoid iodine supplements while on lithium unless directed by your endocrinologist. Monitor thyroid function regularly. Kelp and seaweed supplements are high in iodine and should be avoided.
NutriStack